28.02.2013 Views

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

168 Kathleen Kaiser-Rogers and Kathleen Rao<br />

female gametogenesis are thought to affect our respective predispositions to producing specific types<br />

<strong>of</strong> de novo rearrangements, other factors, such as the effect <strong>of</strong> imprinting on fetal survival, have also<br />

been proposed to play a role (see Chapter 19).<br />

In theory, chromosome breakage, rearrangement, and reunion can occur during meiosis or mitosis.<br />

Meiotic errors, because they occur prior to conception, would be expected to be present in every<br />

cell <strong>of</strong> the resulting pregnancy. Postconception mitotic errors, in contrast, would be predicted to<br />

produce a mosaic pregnancy containing both normal and abnormal cells. Interestingly, with the exception<br />

<strong>of</strong> mitotically unstable chromosomes such as rings or dicentrics, structural chromosome rearrangements<br />

are rarely seen in mosaic form. Although this observation suggests that many structural<br />

rearrangements might be formed during meiosis, ascertainment bias likely plays a role as well.<br />

Because mosaic individuals typically have milder phenotypes than comparable nonmosaics, they are<br />

less likely to be ascertained and karyotyped. This would be especially true <strong>of</strong> individuals carrying<br />

mosaic balanced rearrangements. Additionally, mosaicism is difficult to detect, particularly when it<br />

is limited to a specific tissue or group <strong>of</strong> tissues, is present at a low level, and/or involves a subtle<br />

structural change.<br />

Differentiating Between Balanced and Unbalanced Structural Rearrangements<br />

Structural rearrangements are <strong>of</strong>ten divided into two general categories: balanced and unbalanced.<br />

Balanced rearrangements contain no net loss or gain <strong>of</strong> genetic information and the individuals who<br />

carry them are generally phenotypically normal. In contrast, additional and/or missing genetic material<br />

is present in individuals who carry unbalanced rearrangements. Just as modifications in the<br />

amount <strong>of</strong> the various ingredients added to any recipe cause changes in the final product, deviation<br />

from the normal disomic genetic complement results in a clinically affected individual.<br />

Although it is easy to define balanced and unbalanced rearrangements, distinguishing between a<br />

truly balanced and an unbalanced rearrangement using traditional cytogenetic techniques is <strong>of</strong>ten<br />

impossible. <strong>The</strong> maximum level <strong>of</strong> resolution obtained using standard microscopy <strong>of</strong> G-banded<br />

prometaphase chromosomes is reported to be 2–5 Mb or 2–5 × 106 bp. This number will vary, however,<br />

depending on the quality <strong>of</strong> the chromosome preparations and the skill <strong>of</strong> the cytogeneticist<br />

examining the karyotype(s). <strong>The</strong> ability to resolve or identify a rearrangement will also be influenced<br />

by the degree to which the banding pattern, overall size, and centromere location <strong>of</strong> an involved<br />

chromosome is altered. Obviously, the more apparent the change, the more likely it is to be detected.<br />

A number <strong>of</strong> molecular cytogenetic techniques such as fluorescence in situ hybridization (FISH),<br />

24-color karyotyping, and comparative genomic hybridization (CGH) are currently being used to<br />

detect submicroscopic or otherwise cryptic rearrangements that cannot be detected using traditional<br />

cytogenetics (see Chapter 17).<br />

Associated Risks<br />

Once a structural chromosome rearrangement is detected, regardless <strong>of</strong> whether it is balanced or<br />

unbalanced, the subsequent steps to take depend on the type <strong>of</strong> specimen that was analyzed.<br />

For prenatal samples or children, parental karyotypes should be obtained to assess whether the<br />

rearrangement has been inherited or represents a de novo mutation. If neither parent is found to be a<br />

carrier <strong>of</strong> the rearrangement, the most likely scenario is that it represents a de novo abnormality rather<br />

than an inherited one. Because the possibility <strong>of</strong> gonadal mosaicism can never be excluded, this<br />

family would be given a very low risk <strong>of</strong> having another child with the same structural abnormality.<br />

Prenatal testing would also be <strong>of</strong>fered for all future pregnancies.<br />

In contrast to the very low recurrence risk quoted to a couple with a child or pregnancy carrying a<br />

de novo rearrangement, the risk <strong>of</strong> chromosomally abnormal conceptions for an adult who carries a<br />

balanced structural rearrangement is much higher. In fact, for some familial rearrangements, the risk<br />

can approach 50%. <strong>The</strong>refore, it is imperative that these families be identified so that they can be

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!